• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

ADMA Biologics Inc - Common Stock (NQ:ADMA)

15.39 -0.31 (-1.97%)
Streaming Delayed Price Updated: 4:00 PM EST, Mar 6, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 3,099,388
Open 15.32
Bid (Size) 15.30 (100)
Ask (Size) 15.68 (100)
Prev. Close 15.70
Today's Range 15.16 - 15.62
52wk Range 13.76 - 25.67
Shares Outstanding 196,357,149
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
ADMA Biologics Announces $125 Million Accelerated Share Repurchase with JPMorgan as Part of a Planned $200 Million 2026 Total Share Repurchase Initiative
March 02, 2026
From ADMA Biologics, Inc.
Via GlobeNewswire
News headline image
ADMA Biologics (ADMA) Q4 2025 Earnings Transcript ↗
February 28, 2026
ADMA Biologics (ADMA) Q4 2025 Earnings Transcript 
Via The Motley Fool

Performance

YTD
-13.9%
-13.9%
1 Month
-3.5%
-3.5%
3 Month
-20.6%
-20.6%
6 Month
-6.3%
-6.3%
1 Year
-9.6%
-9.6%

More News

Read More
ADMA Biologics Inc (NASDAQ:ADMA) Reports Record 2025 Results Driven by ASCENIV, Provides 2026 Outlook ↗
February 25, 2026
Via Chartmill
News headline image
ADMA Biologics Reports Record Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
February 25, 2026
From ADMA Biologics, Inc.
Via GlobeNewswire
News headline image
Earnings Scheduled For November 5, 2025 ↗
November 05, 2025
Via Benzinga
News headline image
Earnings Scheduled For August 6, 2025 ↗
August 06, 2025
Via Benzinga
News headline image
Is ADMA Biologics Gaining or Losing Market Support? ↗
August 01, 2025
Via Benzinga
News headline image
ADMA Biologics to Report Fourth Quarter and Full Year 2025 Financial Results on February 25, 2026
February 18, 2026
From ADMA Biologics, Inc.
Via GlobeNewswire
News headline image
Chime Is Down 27% From Its IPO Price, Yet Posting 29% Revenue Growth: Why This New $15 Million Bet Stands Out ↗
February 14, 2026
Via The Motley Fool
Topics Initial Public Offering Regulatory Compliance
News headline image
Solaris Stock Is Up 100% This Past Year, and One Fund Is Betting $29 Million on More Growth ↗
February 14, 2026
Via The Motley Fool
Topics Energy
News headline image
Stock Up 40% in a Year, $706 Million in Quarterly Sales: Why Boot Barn’s Trimmed Stake Deserves a Look ↗
February 14, 2026
Via The Motley Fool
Topics Regulatory Compliance
News headline image
ADMA Biologics Announces Preliminary Full Year 2025 Unaudited Total Revenue and Provides Business Update
January 12, 2026
From ADMA Biologics, Inc.
Via GlobeNewswire
News headline image
ADMA Biologics to Present at the J.P. Morgan Healthcare Conference on January 12, 2026
January 05, 2026
From ADMA Biologics, Inc.
Via GlobeNewswire
News headline image
This Biotech Is Up 194% in a Year but One Investor Took Millions Off the Table ↗
December 28, 2025
Via The Motley Fool
Topics Regulatory Compliance
News headline image
ANI Stock Is Up 49% This Past Year, Revenue Is Surging, and One Fund Still Walked Away ↗
December 28, 2025
Via The Motley Fool
Topics Regulatory Compliance
News headline image
ADMA Biologics Inc (NASDAQ:ADMA) Emerges as a Top GARP Investment Candidate ↗
December 05, 2025
Via Chartmill
News headline image
ADMA Biologics Announces Third Quarter 2025 Financial Results and Provides Business Update
November 05, 2025
From ADMA Biologics, Inc.
Via GlobeNewswire
News headline image
This Small-Cap Fund Just Dumped $7 Million in ADMA Stock — Here’s Why ↗
November 01, 2025
Via The Motley Fool
News headline image
ADMA Biologics to Report Third Quarter 2025 Financial Results on November 5, 2025
October 29, 2025
From ADMA Biologics, Inc.
Via GlobeNewswire
News headline image
Redwire Posts Downbeat Q2 Results, Joins Tandem Diabetes Care, Fortinet, Symbotic And Other Big Stocks Moving Lower In Thursday's Pre-Market Session ↗
August 07, 2025
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
August 07, 2025
Via Benzinga
News headline image
Why Groupon Shares Are Trading Higher By Around 28%; Here Are 20 Stocks Moving Premarket ↗
August 07, 2025
Via Benzinga
News headline image
Adma Biologics (ADMA) Q2 Revenue Up 14% ↗
August 06, 2025
Via The Motley Fool
Topics Economy
News headline image
ADMA Biologics Announces Second Quarter 2025 Financial Results and Provides Business Update
August 06, 2025
From ADMA Biologics, Inc.
Via GlobeNewswire
News headline image
ADMA Biologics to Report Second Quarter 2025 Financial Results on August 6, 2025
July 30, 2025
From ADMA Biologics, Inc.
Via GlobeNewswire

Frequently Asked Questions

Is ADMA Biologics Inc - Common Stock publicly traded?
Yes, ADMA Biologics Inc - Common Stock is publicly traded.
What exchange does ADMA Biologics Inc - Common Stock trade on?
ADMA Biologics Inc - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for ADMA Biologics Inc - Common Stock?
The ticker symbol for ADMA Biologics Inc - Common Stock is ADMA on the Nasdaq Stock Market
What is the current price of ADMA Biologics Inc - Common Stock?
The current price of ADMA Biologics Inc - Common Stock is 15.39
When was ADMA Biologics Inc - Common Stock last traded?
The last trade of ADMA Biologics Inc - Common Stock was at 03/06/26 04:00 PM ET
What is the market capitalization of ADMA Biologics Inc - Common Stock?
The market capitalization of ADMA Biologics Inc - Common Stock is 3.02B
How many shares of ADMA Biologics Inc - Common Stock are outstanding?
ADMA Biologics Inc - Common Stock has 3B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap